First, study treatments were not masked due to the different dosing frequency, titration Table 4. Hypoglycemia Eventsa Hypoglycemia event Tirzepatide Insulin lispro (n = 708) 15 mg (n = 236) 10 mg (n = 238) 5 mg (n = 243) Pooled (n = 717) No. (%) Episodes (events/ patient-year of exposure)No. (%) Episodes (events/ patient-year of exposure) No. (%) Episodes (events/ patient-year of exposure) No. (%) Episodes (events/ patient-year of exposure) No. (%) Episodes (events/ patient-year of exposure) Severe hypoglycemiab 0 0 3 (1.3) 17 (0.05) 0 0 3 (0.4) 17 (0.01) 30 (4.2) 89 (0.16) Relative rate (95% CI) 0 0.29 (0.07 to 1.18) 0 0.08 (0.02 to 0.26) NA Severe hypoglycemia that required hospitalization or documented medical help or was life threatening)a 0 0 2 (0.8) 11 (0.03) 0 0 2 (0.3) 11 (0.01) 25 (3.5) 36 (0.06) Relative rate (95% CI) 0 0.46 (0.11 to 1.84) 0 0.14 (0.04 to 0.53) NA Blood glucose level less than 54 mg/dL or severe hypoglycemia 25 (10.6) 54 (0.23) 22 (9.2) 156 (0.41) 29 (11.9) 158 (0.59) 76 (10.6) 368 (0.41) 340 (48.0) 2796 (4.38) Relative rate (95% CI) 0.05 (0.03 to 0.09) 0.09 (0.04 to 0.24) 0.13 (0.04 to 0.46) 0.09 (0.05 to 0.18) NA Blood glucose level 70 mg/dL or less or severe hypoglycemia 88 (37.3) 604 (2.3) 89 (37.4) 699 (2.6) 86 (35.4) 736 (2.6) 263 (36.7) 2039 (2.5) 519 (73.3) 12716 (18.4) Relative rate (95% CI) 0.13 (0.09 to 0.18) 0.14 (0.09 to 0.23) 0.14 (0.09 to 0.22) 0.14 (0.10 to 0.18) NA Abbreviation: NA, not applicable. 
    